Literature DB >> 7676645

Eradication of persistent reovirus infection from a B-cell hybridoma.

T S Dermody1, J D Chappell, J G Hofler, W Kramp, K L Tyler.   

Abstract

The 2G10 B-cell hybridoma was found to be persistently infected with reovirus serotype 3 (RV3). The persistently infected 2G10 culture produced approximately 1 x 10(8) plaque-forming units of virus per milliliter of culture lysate, and a majority of cells in the culture were infected, as determined by infectious center assay and immunocytochemistry. Cure of the persistent infection was achieved by passaging 2G10 cells for 33 days (12 passages) in medium containing polyclonal anti-RV3 antiserum and a monoclonal antibody specific for the RV3 attachment protein. After several passages in antibody-free medium, cured 2G10 cells had (1) nondetectable levels of RV3 in cell-culture lysates, (2) no infectious centers per 3 x 10(5) cells, (3) no immunocytochemically detectable RV3 antigen, and (4) no detectable reovirus-specific RNA by reverse transcription-polymerase chain reaction amplification. Additionally, mice inoculated with cured 2G10 cell lysates did not generate antibodies directed against RV3. These observations demonstrate that persistent reovirus infection of a B-cell hybridoma can be cured by passage in medium containing anti-reovirus antibodies and suggest that the maintenance of this persistent infection is dependent on horizontal cell-to-cell transmission of virus in the culture.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7676645     DOI: 10.1006/viro.1995.1483

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Persistent reovirus infections of L cells select mutations in viral attachment protein sigma1 that alter oligomer stability.

Authors:  G J Wilson; J D Wetzel; W Puryear; R Bassel-Duby; T S Dermody
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

2.  Efficiency of viral entry determines the capacity of murine erythroleukemia cells to support persistent infections by mammalian reoviruses.

Authors:  J D Wetzel; J D Chappell; A B Fogo; T S Dermody
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

3.  Adaptation of reovirus to growth in the presence of protease inhibitor E64 segregates with a mutation in the carboxy terminus of viral outer-capsid protein sigma3.

Authors:  D H Ebert; J D Wetzel; D E Brumbaugh; S R Chance; L E Stobie; G S Baer; T S Dermody
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Detection of mammalian reovirus RNA by using reverse transcription-PCR: sequence diversity within the lambda3-encoding L1 gene.

Authors:  Thomas P Leary; James C Erker; Michelle L Chalmers; Andrea T Cruz; J Denise Wetzel; Suresh M Desai; Isa K Mushahwar; Terence S Dermody
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

5.  Reovirus variants selected during persistent infections of L cells contain mutations in the viral S1 and S4 genes and are altered in viral disassembly.

Authors:  J D Wetzel; G J Wilson; G S Baer; L R Dunnigan; J P Wright; D S Tang; T S Dermody
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence.

Authors:  W Chen; R S Baric
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro.

Authors:  T Alain; M Kim; R N Johnston; S Urbanski; A E Kossakowska; P A Forsyth; P W K Lee
Journal:  Br J Cancer       Date:  2006-10-03       Impact factor: 7.640

8.  A plasmid-based reverse genetics system for animal double-stranded RNA viruses.

Authors:  Takeshi Kobayashi; Annukka A R Antar; Karl W Boehme; Pranav Danthi; Elizabeth A Eby; Kristen M Guglielmi; Geoffrey H Holm; Elizabeth M Johnson; Melissa S Maginnis; Sam Naik; Wesley B Skelton; J Denise Wetzel; Gregory J Wilson; James D Chappell; Terence S Dermody
Journal:  Cell Host Microbe       Date:  2007-04-19       Impact factor: 21.023

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.